Open Clinical Trials
U.S. HIV/AIDS Trial Databases
U.S. Non-HIV Trial Databases
Specific U.S. Nationwide Studies
- AIDS Clinical Trial Group Trials Open for Enrollment (Regularly Updated)
- ESPRIT: Interleukin Study (Regularly Updated)
A large-scale, randomized, international study of the effectiveness of IL-2 in HIV-positive people with CD4+ counts over 300.
- The Neurologic AIDS Research Consortium (Regularly Updated)
- The U.S. Military HIV Research Program (Regularly Updated)
- Women's Interagency HIV Study (Regularly Updated)
A large, long-running, ongoing investigation of the clinical, laboratory and psychosocial aspects of HIV infection in women.
- U.S. Study Seeks Volunteers to Test Benefits of Testosterone Gel in Older Men (November 2, 2009)
A study is recruiting men across the U.S. age 65 and older to test whether the testosterone gel AndroGel can help offset health problems such as anemia, heart disease, muscle loss and decreased sex drive.
From Penn Medicine
- Can Raltegravir Further Reduce Viral Load? (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Maraviroc for CD4 Cell Recovery (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Once-Daily Raltegravir for Treatment-Naive Patients (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Rilpivirine (TMC278) for Treatment-Naive Patients (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Vaginal Microbicides (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Vicriviroc in People With Dual/Mixed-Tropic HIV (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- The Setpoint Study (Study A5217) (May/June 2008)
A randomized study comparing immediate treatment vs. treatment as indicated in newly-infected HIV-positive patients.
In Positively Aware, from Test Positive Aware Network
- Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients (April 15, 2008)
Novel nucleoside-sparing regimen designed to avoid risk of toxicity associated with nucleoside class of HIV drugs.
From Schering-Plough
- New Kind of Antiretroviral, KP-1461, Clinical Trial Recruiting; Interview With Stephen Becker, M.D. (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News
- Tibotec Therapeutics Announces Initiation of the Largest U.S. Clinical Study Examining HIV Treatment in Treatment-Experienced Adult Women (September 28, 2006)
GRACE trial to explore gender-related differences in response to Prezista-based HIV therapy.
From Tibotec Therapeutics
Trial Databases (Outside U.S.)
Specific Trials (Outside U.S.)
- EuroSIDA: Impact of Antiretrovirals on HIV-Positive Europeans (Regularly Updated)
A very large, prospective, observational cohort study spanning the European continent.
- SPARTAC Study (April 8, 2006)
Clinical trial underway in the United Kingdom examining whether short-term treatment in recently infected people can delay the start of long-term therapy.
From Medical Research Council Clinical Trials Unit
|
|
Advertisement
|